Astrana Health, Inc.
ASTH
$40.81
$3.027.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 15.69M | 10.29M | 15.22M | 2.58M |
| Total Other Revenue | 972.52M | 949.42M | 940.24M | 940.83M | 654.81M |
| Total Revenue | 972.52M | 965.10M | 950.53M | 956.05M | 654.81M |
| Cost of Revenue | 868.50M | 859.36M | 855.48M | 858.86M | 576.84M |
| Gross Profit | 104.02M | 105.74M | 95.04M | 97.19M | 77.97M |
| SG&A Expenses | 54.15M | 61.16M | 61.05M | 52.09M | 50.73M |
| Depreciation & Amortization | 15.55M | 15.48M | 16.40M | 15.60M | 6.90M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 938.20M | 935.99M | 932.93M | 926.54M | 634.47M |
| Operating Income | 34.32M | 29.11M | 17.60M | 29.51M | 20.34M |
| Income Before Tax | 27.21M | 19.71M | 7.51M | 5.67M | 16.83M |
| Income Tax Expenses | 8.76M | 6.58M | 944.00K | 4.59M | 6.61M |
| Earnings from Continuing Operations | 18.45M | 13.13M | 6.56M | 1.08M | 10.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.29M | 1.31M | -563.00K | -704.00K | -793.00K |
| Net Income | 19.74M | 14.44M | 6.00M | 373.00K | 9.42M |
| EBIT | 34.32M | 29.11M | 17.60M | 29.51M | 20.34M |
| EBITDA | 49.87M | 44.59M | 34.00M | 45.11M | 27.24M |
| EPS Basic | 0.40 | 0.30 | 0.12 | 0.01 | 0.19 |
| Normalized Basic EPS | 0.31 | 0.27 | 0.02 | 0.20 | 0.20 |
| EPS Diluted | 0.40 | 0.29 | 0.12 | 0.01 | 0.19 |
| Normalized Diluted EPS | 0.31 | 0.27 | 0.02 | 0.20 | 0.20 |
| Average Basic Shares Outstanding | 49.12M | 48.85M | 49.23M | 49.22M | 49.19M |
| Average Diluted Shares Outstanding | 49.78M | 49.05M | 49.53M | 49.47M | 49.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.48% | 0.72% | 37.34% | -- | 8.26% |